Risk that deterioration in an affiliated company's financial condition due to an infectious disease leads to additional impairment losses on shares in affiliated companies or reversals of allowances for loans to affiliated companies. A theme focused specifically on the valuation and recoverability of investments in and loans to affiliated companies.